FDA Plans to Warn J&J Covid-19 Vaccine Raises Risk of Rare Neurological Condition

The agency plans to add the warning language to the J&J shot’s label, after finding a handful of cases of Guillain-Barré syndrome among the millions of people who have gotten the vaccine.

Facebook Acquisition Review Shows EU’s New Antitrust Power

The company has hit a new obstacle in Europe for its...

Activision Replaces Blizzard Head as It Grapples With Gender-Bias Lawsuit

A California agency accused executive J. Allen Brack and others at...

Alibaba Posts Quarterly Profit Lifted by E-Commerce and Cloud Computing

The tech giant’s profit attributable to shareholders was about $6.99 billion...

American Dream Aims to Ride Luxury Wave

The sprawling shopping mall and entertainment center outside Manhattan is opening...